Advanced Cancer Outcomes Predicted Using Model Based on Circulating Tumor DNA Metrics
Researchers developed a ctDNA-based machine learning model for predicting metastatic non-small cell lung cancer response to immunotherapy and related survival outcomes.
In Brief This Week: PerkinElmer, Bruker, Calibre Scientific, Prenetics, T2 Biosystems, More
News items for the week of March 13, 2023.
Point32Health Expands Coverage of Foundation Medicine CDx Tests for Patients With Advanced Cancer
FoundationOne CDx and FoundationOne Liquid CDx comprehensive genomic profiling tests will be available to Point32Health patients with advanced solid tumors.
Roche, Janssen Expand Companion Diagnostic Collaboration
The new agreement allows the companies to collaborate with multiple technologies, including digital pathology and immunoassays.
Roche Diagnostics Revenues Essentially Flat in 2022
Molecular lab revenues fell 17 percent during the year, while core lab sales were up 3 percent and point-of-care revenues grew 15 percent.
Oct 20, 2022
Oct 18, 2022